Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Mesoblast Ltd
NASDAQ:MESO
Mesoblast Ltd
NASDAQ:MESO
Price:
13.75
USD
-1.36%
Market Closed
Market Cap:
$1.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Mesoblast Ltd
NASDAQ:MESO
|
AU |
|
E
|
ERA Graharealty Tbk PT
IDX:IPAC
|
ID |
|
Valbiotis SA
F:8JD
|
FR |
|
Pharma Mar SA
F:PMRA
|
ES |
|
H
|
Hellofresh SE
OTC:HELFY
|
DE |
|
Optimus Group Co Ltd
OTC:OPTGF
|
JP |
|
Regal Partners Ltd
F:OC7
|
AU |
|
NEXTDC Ltd
F:2NX
|
AU |
|
D
|
Dicera Holdings JSC
VN:DC4
|
VN |
|
K
|
Ksolves India Ltd
NSE:KSOLVES
|
IN |
|
G
|
Great Eagle Holdings Ltd
XMUN:GHK
|
BM |
Wall St Price Targets
MESO Price Forecast
Based on 5 analysts
Based on 5 analysts
+84% Upside
from
$13.75
today
Mesoblast Ltd (MESO)’s 12-month stock price forecast through October 2027 has a consensus target of $25.26, implying 84% upside. The forecast is based on price targets from 5 Wall Street analysts.
MESO Analyst Rating
Based on 3 analysts
Based on 3 analysts
Analysts rate MESO Buy, with 3 of 3 recommending Buy or Strong buy.
Mesoblast Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MESO's stock price target?
Price Target
25.26
USD
25.26
USD
According to Wall Street analysts, the average 1-year price target for MESO is 25.26 USD with a low forecast of 20.38 USD and a high forecast of 32.5 USD.
What is the Revenue forecast for Mesoblast Ltd?
Projected CAGR
72%
72%
Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is 72%.
What is the Gross Profit forecast for Mesoblast Ltd?
Projected CAGR
58%
58%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 3 years is 58%.